More work is necessary to understand the molecular underpinnings of NDD-related HNRNP variation, especially since compounds utilized in diseases such as addiction and cancer are available to target, both up- and downregulating, a subset of hnRNPs [83, 137]. The gene discussed is HNRNPC; the disease is Neurodevelopmental delay.